CSP - 481, The Home INR Study (THINRS).
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Warfarin (Primary)
- Indications Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms THINRS
- 15 Apr 2014 Biomarkers information updated
- 16 Oct 2008 New trial record.